ID4: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 28: | Line 28: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medical genetics]] | [[Category:Medical genetics]] | ||
{{No image}} | |||
Revision as of 01:10, 11 February 2025
ID4 or Inhibitor of DNA binding 4 is a protein that in humans is encoded by the ID4 gene. It is a member of the inhibitor of DNA binding family, members of which are transcriptional regulators that contain a helix-loop-helix (HLH) domain but not a basic domain.
Function
Members of the ID family inhibit the functions of basic helix-loop-helix transcription factors in a dominant-negative manner by suppressing their heterodimerization partners through the HLH domains. This protein may play a role in negatively regulating cell differentiation. A mutation in this gene has been associated with a specific type of adenocarcinoma.
Clinical significance
ID4 has been implicated in various types of cancer, including breast cancer, ovarian cancer, and glioblastoma. It is thought to act as a tumor suppressor in some contexts, but may promote cancer growth in others. The exact mechanisms by which ID4 influences cancer development and progression are still being investigated.
See also
References
<references />
External links
